BRAK LABS Peptide research, plainly written

price comparison

What BPC-157 costs

What moves the price, how to compare two listings, and why no figures appear here. This site sells nothing and links to no seller today.

Last Reviewed Editorial policy Methodology

What BPC-157 sells for is driven by four things, and only one of them is about the material in the vial. This page sets out all four and explains how to compare two listings without being misled by the one that varies most.

It carries no prices, and that is deliberate rather than an omission. This site sells nothing and links to no seller, and the editorial standard it publishes under puts prices on the list of things it does not print, alongside carts, order buttons and stock indicators. A price reprinted here would be the one element on the site that reads as commerce, and the useful half of a price page is the part that survives without it.

What is worth knowing is structural. This is the highest-volume compound in the category, which means it has the most sellers, the widest range of vial sizes and the largest apparent spread between listings. Almost all of that spread is packaging rather than product.

Not medical advice

This page reports what has been documented about a compound. It is not medical advice, not a diagnosis, not a dosing protocol, and not a recommendation to obtain or use anything described here. Talk to a licensed clinician about anything concerning your health. Read the full disclaimer.

Reviewed against editorial standards Updated

What drives the price

Vial size is the largest single factor and the one most often left out of a comparison. The amount in the vial varies far more widely across this compound's listings than the number attached to them does, so two listings that look comparable can differ by an order of magnitude in what they contain.

Synthesis cost is the second, and it is why BPC-157 is not among the cheapest peptides sold. Fifteen residues is fifteen coupling steps, each one adding a purification problem, where a tripeptide is three. Length drives cost in this market more reliably than anything else about a molecule.

Presentation is the third. Capsules, oral sprays and pre-mixed formats carry a formulation cost and a different apparent price from a vial of powder, and they are different products even where the label names the same substance. This compound is sold in more presentations than most, which widens the spread further.

Testing is the fourth and the least visible. A certificate carrying an independent identity test, a net peptide content figure, an endotoxin result and a sterility result costs real money to produce. One carrying none of those costs almost nothing. Two listings at the same number can sit on opposite sides of that line, and the number will not say which is which.

Where it is sold

This site links to no seller today, so the table below is empty. The moment any outbound store link appears on this page, three things ship in the same deploy: the link carries rel="sponsored nofollow", a visible disclosure sits beside it naming the relationship as common ownership rather than a commission, and the same disclosure goes into the footer of every page. That is written down in the editorial policy before there is anything to disclose, which is the only time such a commitment is worth making.

Sellers listing BPC-157. Empty until this site links to one
SellerFormatRelationship
No sellers listed.

How to read a price in this market

Cost per unit weight and cost per vial are different quantities, and only the first one says anything. Most of the apparent spread between listings disappears once the amount in the vial is accounted for.

A price says nothing about identity or content. Nothing about a listed figure establishes what is in the vial, how much of it is there, which form it is, or whether it was made under conditions that would matter. Those questions are answered by a certificate of analysis, and what a certificate does and does not prove is set out in the sourcing section of the evidence review.

Research-use-only labelling does not change what a sale is. FDA has rejected that framing where evidence from a seller's own website showed intent for human use, reasoning from the websites themselves. This page carries no numbered references, so it states no agency action here; the dated enforcement record, with its documents, is in the regulatory section of the evidence review. A page like this one is part of the evidence a regulator would read, which is one of the reasons it carries no seller.

This site links to no seller today. When that changes, the link will carry rel sponsored nofollow, a visible disclosure will sit beside it naming the relationship as common ownership rather than a commission, and the same disclosure will go into the footer of every page in the same deploy.

What a certificate of analysis proves, and what it does not, is covered in the sourcing section of the evidence review.

Frequently asked questions

Why is BPC-157 more expensive than some peptides sold alongside it?

Length, mostly. Fifteen residues is fifteen coupling steps in synthesis and a purification problem that compounds at each one, where a three-residue peptide is three steps. That is a manufacturing fact rather than a statement about quality, and a higher price carries no information about what is in the vial.

Does a higher price mean a better product?

Nothing about how this market prices supports that reading. Two listings at the same number can differ entirely in whether the material was independently tested, and the number does not reveal which is which. For this compound a listing may also not say whether it holds the free base or the acetate salt, which are separate substances with separate identifiers.

How should two listings be compared?

Cost per unit weight and cost per vial are different quantities, and vial sizes for this compound vary more widely than the numbers attached to them. Once that is accounted for, every question that remains is about the certificate of analysis: who tested it, which lot it covers, which form it covers, and what was actually measured.

Why does this page carry no prices?

Because the editorial standard this site publishes under puts prices on the list of things it does not print, next to carts, order buttons and stock indicators. BRAK Labs links to storefronts under common ownership, which makes anything published here readable as material about what those storefronts sell, and a price range is the one element on a page that reads as commerce rather than as reporting. Everything on this page that is not a figure is the part worth having anyway.

Does this site sell BPC-157?

No. BRAK Labs sells nothing. There is no cart, no order path and no product page anywhere on this site, and today it links to no seller at all. If that ever changes, the link will carry rel sponsored nofollow with a visible disclosure beside it naming the relationship, and the same disclosure will appear in the footer of every page in the same deploy.

What does research use only on a label mean?

Less than it appears to. FDA has rejected research-use-only framing where evidence from a seller's own website, including social posts and gated forum content, showed intent for human use. The label is one piece of evidence among many, and the agency looks at all of them. The dated enforcement record is in the regulatory section of the evidence review, which carries the documents.